The evidence of Hsp90 involvement in immune regulation combined with our own findings in Her2+ and TNBC tumors provides a compelling opportunity to explore how surface Hsp90 expression on carcinoma cells relates to the immune cell milieu in the tumor microenvironment. Here, ERBB2 is linked to carcinoma.